Endoscopy solutions achieved nearly 20% growth and now comprise 60% of revenue, with strong gains in pulmonology, urology, and ENT. New product launches and a unified software platform support continued leadership, while operational improvements and a debt-free position enable investment in growth. Guidance was raised following a robust Q1.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.